Oxford Nanopore Technologies, the company delivering a new generation of nanopore-based molecular sensing technology, and bioMérieux, a world leader in the field of in vitro diagnostics, are teaming up to improve health outcomes globally by exploring selected opportunities to bring nanopore sequencing to the infectious disease diagnostics market.
Biotechnology company Maxion Therapeutics has been awarded a £2 million grant from Innovate UK, as part of its Biomedical Catalyst 2022 Round 2: Industry-led R&D funding competition. The funds will support the use of Maxion’s proprietary KnotBody platform www.maxiontherapeutics.com/#technology to develop antibodies to treat autoimmune diseases (AID) with high unmet clinical need.
Pfizer and Thermo Fisher Scientific have agreed to collaborate to help increase local access to next-generation sequencing (NGS)-based testing for lung and breast cancer patients in more than 30 countries across Latin America, Africa, the Middle East and Asia where advanced genomic testing has previously been limited or unavailable. Access to local NGS testing can […]
Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, has appointed Kenneth Hitchner, BA MBA, as Chairman of its Board of Directors. The announcement follows a series of appointments to the Company’s senior leadership team, as part of its ambitious global growth strategy.
Xyall and Indica Labs have entered into a global strategic partnership designed to bridge the gap between histology and molecular pathology. It unites Xyall’s unique automated tissue dissection solutions with Indica Labs’ AI-powered, diagnostic digital pathology platform.
Certest Biotec, the University of Zaragoza and the University of the Basque Country are working on developing a new inhaled vaccine against tuberculosis, as a reinforcement of the current and future vaccines.
Scientists identify new biomarker that may predict treatment response to chemoimmunotherapy Cutting-edge cancer treatments like immunotherapy are offering new hope for patients, often in combination with more common approaches such as chemotherapy. But determining the best treatment combination isn’t always straightforward. Many patients spend valuable time on expensive therapies with serious side effects that aren’t […]
Researchers discover a way to improve nonviral gene editing as well as a new type of DNA repair Gene editing is a powerful method for both research and therapy. Since the advent of the Nobel Prize-winning CRISPR/Cas9 technology, a quick and accurate tool for genome editing discovered in 2012, scientists have been working to explore […]
Siemens Healthineers to distribute Scopio Labs’ full-field digital cell morphology technology Siemens Healthineers has agreed to distribute Scopio Labs’ full-field digital cell morphology technology, which will enable clinical labs to examine patient blood cell samples digitally instead of under a microscope. The Scopio X100 and Scopio X100HT imaging platforms will complement the Siemens Healthineers systems […]
Agilent acquires e-MSion and their ExD cell technology Agilent Technologies has acquired e-MSion, an early-stage company behind the innovative electron capture dissociation (ECD) technology known as the ExD cell.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
